Key result
Channelopathies drive ~10% of sudden cardiac deaths and require genotype-specific management.
Why the study?
Channelopathies constitute a significant proportion of sudden cardiac death worldwide, prompting a review of the genetic basis of primary electric disorders to decode pathophysiology and aid prevention.
Design
Review
Authors
Loading...
Supports genetic testing in unexplained SCD cases; leaves open validation of genotype-guided therapies in prospective studies.
Understanding the genetic details of channelopathies improves knowledge and decodes the pathophysiology of malignant arrhythmias to aid in the prevention of sudden cardiac death.
Abdullah Alabdulgader (2021) conducted a review in Channelopathies and Sudden Cardiac Death. Channelopathies, primarily caused by genetic mutations in ion channels, account for approximately 10% of sudden cardiac deaths worldwide and require genotype-specific approaches for management.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: